These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21602603)

  • 1. Structure-cardiovascular activity relationships in a group of new 8-alkylamino-1,3-dimethyl-7-(2-hydroxy-3-aminopropyl)-3,7-dihydro-1H-purine-2,6-diones.
    Chłoń-Rzepa G; Zmudzki P; Pawłowski M; Zygmunt M; Filipek B
    Pharmacol Rep; 2011; 63(2):476-86. PubMed ID: 21602603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and cardiovascular activity of new 8-alkylamino-1,3-dimethyl-7-(2-hydroxy-3- piperazinopropyl)-3,7-dihydro-1H-purine-2,6-diones.
    Chłoń-Rzepa G; Pawłowski M; Zygmunt M; Filipek B; Maciag D
    Pol J Pharmacol; 2004; 56(6):755-66. PubMed ID: 15662088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
    Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
    Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary evaluation of pharmacological properties of some xanthone derivatives.
    Marona H; Szkaradek N; Rapacz A; Filipek B; Dybała M; Siwek A; Cegła M; Szneler E
    Bioorg Med Chem; 2009 Feb; 17(3):1345-52. PubMed ID: 19131251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacological evaluation of new 1-[3-(4-phenylpiperazin-1-yl)-propyl]- and 1-[3-(4-phenylpiperidine)-propyl]- 3-aryl-3-alkyl-pyrrolidin-2-one derivatives with antiarrhythmic and antihypertensive activity.
    Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
    Acta Pol Pharm; 2009; 66(6):649-62. PubMed ID: 20050529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Search for new antiarrhythmic and hypotensive compounds. Synthesis, antiarrhythmic, antihypertensive, and alpha-adrenoceptor blocking activity of novel 1-[(2-hydroxy-3-amino)]-propylpyrrolidin-2-one derivatives.
    Filipek B; Sapa J; Malawska B; Kulig K; Antkiewicz-Michaluk L
    Arch Pharm (Weinheim); 1997 Jul; 330(7):225-31. PubMed ID: 9311302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxypropyl]-pyrrolidin-2-one derivatives with anti-arrhythmic, hypotensive, and alpha-adrenolytic activity.
    Kulig K; Sapa J; Maciag D; Filipek B; Malawska B
    Arch Pharm (Weinheim); 2007 Sep; 340(9):466-75. PubMed ID: 17806129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, antiarrhythmic, and antihypertensive effects of novel 1-substituted pyrrolidin-2-one and pyrrolidine derivatives with adrenolytic activity.
    Malawska B; Kulig K; Filipek B; Sapa J; Maciag D; Zygmunt M; Antkiewicz-Michaluk L
    Eur J Med Chem; 2002 Mar; 37(3):183-95. PubMed ID: 11900863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic properties of phenylpiperazine derivatives of phenytoin with α₁-adrenoceptor affinities.
    Handzlik J; Bajda M; Zygmunt M; Maciąg D; Dybała M; Bednarski M; Filipek B; Malawska B; Kieć-Kononowicz K
    Bioorg Med Chem; 2012 Apr; 20(7):2290-303. PubMed ID: 22381672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Pharmacological Activity of a New Series of 1-(1H-Indol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol Analogs.
    Bednarski M; Otto M; Dudek M; Kołaczkowski M; Bucki A; Siwek A; Groszek G; Maziarz E; Wilk P; Sapa J
    Arch Pharm (Weinheim); 2016 Mar; 349(3):211-23. PubMed ID: 26853441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of some xanthone derivatives for anti-arrhythmic, hypotensive properties and their affinity for adrenergic receptors.
    Marona H; Szkaradek N; Kubacka M; Bednarski M; Filipek B; Cegla M; Szneler E
    Arch Pharm (Weinheim); 2008 Feb; 341(2):90-8. PubMed ID: 18240129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic and hypotensive activities of 1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-pyrrolidin-2-one (MG-1(R,S)) and its enantiomers.
    Sapa J; Filipek B; Nowiński L
    Pharmacol Rep; 2011; 63(2):455-63. PubMed ID: 21602601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of some aroxyethylamine derivatives for hypotensive properties and their affinities for adrenergic receptors.
    Maciag D; Filipek B; Czekaj T; Marona H; Nowak G
    Pharmazie; 2003 Dec; 58(12):899-905. PubMed ID: 14703970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular activity of the chiral xanthone derivatives.
    Szkaradek N; Rapacz A; Pytka K; Filipek B; Żelaszczyk D; Szafrański P; Słoczyńska K; Marona H
    Bioorg Med Chem; 2015 Oct; 23(20):6714-24. PubMed ID: 26386822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New 8-aminoalkyl derivatives of purine-2,6-dione with arylalkyl, allyl or propynyl substituents in position 7, their 5-HT1A, 5-HT2A, and 5-HT7 receptor affinity and pharmacological evaluation.
    Chłoń-Rzepa G; Zmudzki P; Satała G; Duszyńska B; Partyka A; Wróbel D; Jastrzębska-Więsek M; Wesołowska A; Bojarski AJ; Pawłowski M; Zajdel P
    Pharmacol Rep; 2013; 65(1):15-29. PubMed ID: 23563020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of new 2-(4,5-dihydro-1H-imidazol-2-yl)-3,4-dihydro-2H-1,4-benzoxazine derivatives.
    Touzeau F; Arrault A; Guillaumet G; Scalbert E; Pfeiffer B; Rettori MC; Renard P; Mérour JY
    J Med Chem; 2003 May; 46(10):1962-79. PubMed ID: 12723959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-(Arylamino)-6,7-dihydro-6-methylpyrano[4,3-c]pyrazol-4(1H or 2H)-ones with antipyretic, analgesic, antiarrhythmic, hypotensive and other activities.
    Bruno O; Ranise A; Schenone S; Bondavalli F; D'amico M; Falciani M; Berrino L; Rossi F
    Farmaco; 1993 Dec; 48(12):1697-708. PubMed ID: 8135993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of in vivo activity of diphenylhydantoin basic derivatives.
    Dylag T; Zygmunt M; Maciag D; Handzlik J; Bednarski M; Filipek B; Kieć-Kononowicz K
    Eur J Med Chem; 2004 Dec; 39(12):1013-27. PubMed ID: 15571863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic, hypotensive and α1-adrenolytic properties of new 2-methoxyphenylpiperazine derivatives of xanthone.
    Rapacz A; Pytka K; Sapa J; Kubacka M; Filipek B; Szkaradek N; Marona H
    Eur J Pharmacol; 2014 Jul; 735():10-6. PubMed ID: 24751714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic and α-Adrenoceptor Antagonistic Properties of Novel Arylpiperazine Derivatives of Pyrrolidin-2-one.
    Zaręba P; Dudek M; Lustyk K; Siwek A; Starowicz G; Bednarski M; Nowiński L; Zygmunt M; Sapa J; Malawska B; Kulig K
    Arch Pharm (Weinheim); 2015 Dec; 348(12):861-7. PubMed ID: 26523954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.